A hub to help academic entrepreneurs commercialize biomedical discoveries.
Official title: Gulf Coast Consortia (GCC) Research Evaluation and Commercialization Hub
Funded at Texas A&m University Health Science Ctr · NIH-10932911 · Data updated 2026-11-12
This study is all about helping smart people in the Texas Medical Center turn their medical discoveries into real products that can help patients, by giving them the support, training, and guidance they need to succeed.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | September 25, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $995,246 |
| NIH project number | 5U01GM152516-02 |
| Project ID | NIH-10932911 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include patients with conditions that could be addressed by new biomedical technologies developed through this commercialization process.
✕Less likely to help
Patients who may not receive benefit from this research include those with conditions that are not targeted by the specific innovations developed through the hub.
What this research studies
This research initiative aims to establish the Gulf Coast Consortium Research Evaluation and Commercialization Hub (GCC-REACH) to support academic entrepreneurs in the Texas Medical Center. By providing resources, training, and mentorship from experienced biotech executives, the hub will help these innovators validate and commercialize their biomedical discoveries. The program focuses on creating strategic timelines and milestones to ensure that promising research can transition effectively from the lab to clinical applications that benefit patients.
Why it matters
Potential benefit: If successful, this research could lead to more biomedical innovations being brought to market, ultimately improving patient health and well-being.
How similar studies have gone: Other initiatives aimed at supporting the commercialization of biomedical research have shown success in enhancing the transition of discoveries to clinical applications.
Where this research is happening
-
Texas A&m University Health Science Ctr
College Station, United States Active
Researchers
- Principal investigator: Davies, Peter J — Texas A&m University Health Science Ctr
- Study coordinator: Davies, Peter J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.